726 Phase I Results of FT516, an Off-the-shelf, Ipsc-Derived NK Cell Therapy Expressing a High-Affinity, Non-Cleavable CD16 (hncd16) Combined with Avelumab in Patients with Advanced Solid Tumors
Regular and Young Investigator Award Abstracts（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined